FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978608725> ?p ?o ?g. }

• W1978608725 endingPage "1319" @default.
• W1978608725 startingPage "1311" @default.
• W1978608725 abstract "In Brief BACKGROUND: Chronic neuropathic pain is inadequately treated using current therapies, with less than half of patients achieving clinically significant pain relief (defined as more than 50% pain reduction). In this study, we evaluated the AMPA/GluR5 receptor antagonist NS1209 for efficacy, safety, and tolerability in comparison with placebo and lidocaine for the treatment of chronic neuropathic pain and allodynia in patients with peripheral nerve injury. METHODS: A randomized, double-blind, placebo-controlled, three-way crossover study was designed to recruit patients with chronic neuropathic pain for IV treatment with NS1209 (322 mg), lidocaine (5 mg/kg), and placebo. Measures of spontaneous current pain and pain evoked by brush, pinprick, cold, and heat stimulation were performed at screening and at 0, 2, 4, 6, 8, and 24 h after the start of the treatment session. RESULTS: Thirteen patients completed the study. Neither NS1209 nor lidocaine showed a statistically significant effect over placebo on the primary end-point spontaneous current pain, but both compounds exhibited a statistically significant effect on the secondary end-point pain relief of overall spontaneous pain compared with placebo. Similar to lidocaine, NS1209 was superior to placebo in alleviating some key symptoms of neuropathic pain, i.e., evoked types of pain, including mechanical and cold allodynia. CONCLUSIONS: These findings are consistent with those reported for NS1209 in other models of pain and suggest that there is a role for AMPA receptor involvement in neuropathic pain in humans. Furthermore, NS1209 was safe and well tolerated at the given doses with a safety profile similar to placebo. IMPLICATIONS: This pilot study suggests that NS1209, a novel, selective, competitive and potent AMPA/GluR5 receptor antagonist, alleviates certain signs and symptoms of neuropathic pain with an effect profile similar to the sodium channel blocker lidocaine. The findings suggest a role for AMPA-receptor involvement in neuropathic pain in humans, but studies in a larger population are needed." @default.
• W1978608725 created "2016-06-24" @default.
• W1978608725 creator A5000366795 @default.
• W1978608725 creator A5041295986 @default.
• W1978608725 creator A5041298056 @default.
• W1978608725 creator A5066094707 @default.
• W1978608725 date "2009-04-01" @default.
• W1978608725 modified "2023-09-30" @default.
• W1978608725 title "The Efficacy of the AMPA Receptor Antagonist NS1209 and Lidocaine in Nerve Injury Pain: A Randomized, Double-Blind, Placebo-Controlled, Three-Way Crossover Study" @default.
• W1978608725 cites W1988059170 @default.
• W1978608725 cites W2007415551 @default.
• W1978608725 cites W2042549514 @default.
• W1978608725 cites W2047615932 @default.
• W1978608725 cites W2052309611 @default.
• W1978608725 cites W2057439534 @default.
• W1978608725 cites W2062625412 @default.
• W1978608725 cites W2062885664 @default.
• W1978608725 cites W2068185359 @default.
• W1978608725 cites W2075765134 @default.
• W1978608725 cites W2077404583 @default.
• W1978608725 cites W2078200446 @default.
• W1978608725 cites W2083362915 @default.
• W1978608725 cites W2089633836 @default.
• W1978608725 cites W2098605131 @default.
• W1978608725 cites W2100880723 @default.
• W1978608725 cites W2133048825 @default.
• W1978608725 cites W2133316133 @default.
• W1978608725 cites W2158038467 @default.
• W1978608725 cites W2165085297 @default.
• W1978608725 cites W2167667710 @default.
• W1978608725 cites W2169539761 @default.
• W1978608725 doi "https://doi.org/10.1213/ane.0b013e318198317b" @default.
• W1978608725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19299805" @default.
• W1978608725 hasPublicationYear "2009" @default.
• W1978608725 type Work @default.
• W1978608725 sameAs 1978608725 @default.
• W1978608725 citedByCount "39" @default.
• W1978608725 countsByYear W19786087252012 @default.
• W1978608725 countsByYear W19786087252013 @default.
• W1978608725 countsByYear W19786087252014 @default.
• W1978608725 countsByYear W19786087252015 @default.
• W1978608725 countsByYear W19786087252016 @default.
• W1978608725 countsByYear W19786087252017 @default.
• W1978608725 countsByYear W19786087252018 @default.
• W1978608725 countsByYear W19786087252019 @default.
• W1978608725 countsByYear W19786087252021 @default.
• W1978608725 countsByYear W19786087252022 @default.
• W1978608725 countsByYear W19786087252023 @default.
• W1978608725 crossrefType "journal-article" @default.
• W1978608725 hasAuthorship W1978608725A5000366795 @default.
• W1978608725 hasAuthorship W1978608725A5041295986 @default.
• W1978608725 hasAuthorship W1978608725A5041298056 @default.
• W1978608725 hasAuthorship W1978608725A5066094707 @default.
• W1978608725 hasBestOaLocation W19786087251 @default.
• W1978608725 hasConcept C126322002 @default.
• W1978608725 hasConcept C142724271 @default.
• W1978608725 hasConcept C15490471 @default.
• W1978608725 hasConcept C168563851 @default.
• W1978608725 hasConcept C170493617 @default.
• W1978608725 hasConcept C1862650 @default.
• W1978608725 hasConcept C197934379 @default.
• W1978608725 hasConcept C204787440 @default.
• W1978608725 hasConcept C27081682 @default.
• W1978608725 hasConcept C2775991916 @default.
• W1978608725 hasConcept C2777107010 @default.
• W1978608725 hasConcept C2777883359 @default.
• W1978608725 hasConcept C2778375690 @default.
• W1978608725 hasConcept C2779245659 @default.
• W1978608725 hasConcept C2780149897 @default.
• W1978608725 hasConcept C2781118164 @default.
• W1978608725 hasConcept C42219234 @default.
• W1978608725 hasConcept C71924100 @default.
• W1978608725 hasConcept C87813604 @default.
• W1978608725 hasConceptScore W1978608725C126322002 @default.
• W1978608725 hasConceptScore W1978608725C142724271 @default.
• W1978608725 hasConceptScore W1978608725C15490471 @default.
• W1978608725 hasConceptScore W1978608725C168563851 @default.
• W1978608725 hasConceptScore W1978608725C170493617 @default.
• W1978608725 hasConceptScore W1978608725C1862650 @default.
• W1978608725 hasConceptScore W1978608725C197934379 @default.
• W1978608725 hasConceptScore W1978608725C204787440 @default.
• W1978608725 hasConceptScore W1978608725C27081682 @default.
• W1978608725 hasConceptScore W1978608725C2775991916 @default.
• W1978608725 hasConceptScore W1978608725C2777107010 @default.
• W1978608725 hasConceptScore W1978608725C2777883359 @default.
• W1978608725 hasConceptScore W1978608725C2778375690 @default.
• W1978608725 hasConceptScore W1978608725C2779245659 @default.
• W1978608725 hasConceptScore W1978608725C2780149897 @default.
• W1978608725 hasConceptScore W1978608725C2781118164 @default.
• W1978608725 hasConceptScore W1978608725C42219234 @default.
• W1978608725 hasConceptScore W1978608725C71924100 @default.
• W1978608725 hasConceptScore W1978608725C87813604 @default.
• W1978608725 hasIssue "4" @default.
• W1978608725 hasLocation W19786087251 @default.
• W1978608725 hasLocation W19786087252 @default.
• W1978608725 hasLocation W19786087253 @default.
• W1978608725 hasOpenAccess W1978608725 @default.
• W1978608725 hasPrimaryLocation W19786087251 @default.

• next